Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.
  • Page:
  • 1
  • 2
  • 3

Berkeley Minerals (BMR)     

3 monkies - 27 Jan 2011 19:37

Has anybody seen that RHPS has recommended 3 sells one of them being the above? Can see tomorrow being a disasterous day!!!!!!!!

Bullshare - 01 Feb 2017 12:02 - 44 of 47

 
We would like to invite you to our exclusive Shares Investor Evening in Edinburgh on Wednesday 15th Feruary 2017. Following the success of our regular investor events in London and our event last October in Edinburgh we are coming back!
 
This free event offers a unique opportunity to hear from company directors about their latest plans and strategy for their firms' growth and development. You have the opportunity to ask the questions that matter to you and network with fellow investors over drinks and canapés.
Who Should Attend?

The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.

Date:

Wednesday 15th February 2017

Venue:

Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh, EH11TH

Event Timings:
17.30 
Registration and coffee
17.55 
Presentations
• Alex Borrelli, Chairman & CEO - BMR (BMR)
• Jeremy Hawke, Mining & Operations Director - BMR (BMR)
• Ed Molyneux, CEO - FreeAgent (FREE)
• Michael Hunt, CFO - ReNeuron Group (RENE)
• Richard Clemmey, MD - Tertiary Minerals (TYM)
• Martin Perrin, CFO - Vipera (VIP)
20.45 
Drinks reception and canapés
21.45 
Close
AJ Bell Youinvest
AJ Bell Youinvest 

AJ Bell Youinvest is a multi-award winning provider of SIPPs, stocks and shares ISAs, Junior ISAs, Junior SIPPs and share dealing accounts. We offer customers access to a market leading range of investment options, including: shares, funds, ETFs, investment trusts and much more. Our online dealing service starts from just £4.95 and never costs more than £9.95 per deal.

BMR (BMR)
BMR (BMR) 

BMR has successfully developed a proprietary acid/brine leach process that enables it to achieve high metal recoveries from the different tailings deposits.

BMR Group PLC is listed on AIM under the ticker BMR.

The Company is focused on the recovery of lead and zinc from the tailings deposits of Zambia’s oldest mine at Kabwe.

FreeAgent (FREE)
FreeAgent (FREE) 

FreeAgent launched in 2007, hewn from the frustration that managing company finances was just too damn hard for most small businesses and freelancers. Since then we’ve doggedly stuck to our mantra of demystifying accounting and redefining the relationship people have with their finances.

Ambitious? Sure. Crazy? Quite possibly, but we think it might just work.

We’ve won some important awards over the years, but we’re most proud of the lovely things our users say about us, and the super smart and friendly team we’ve built.

We’re based in the Scottish capital Edinburgh, recently described as “Probably the most beautiful city we have ever seen” by The Black Eyed Peas! High praise indeed.

 

ReNeuron Group (RENE)
ReNeuron Group (RENE) 

ReNeuron is a leading, clinical-stage cell therapy development business.  Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need.  

ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments.  The Company’s therapeutic candidates for stroke disability and critical limb ischaemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. 

ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer.

Tertiary Minerals (TYM)
Tertiary Minerals (TYM) 

Tertiary Minerals plc (ticker symbol 'TYM') is an AIM-traded mineral exploration and development company building a significant strategic position in the fluorspar sector.

Fluorspar is an essential raw material in the chemical, steel and aluminium industries with no large scale commercial alternative, or recycling available. Tertiary controls two significant Scandinavian projects (Storuman in Sweden and Lassedalen in Norway) and a large deposit of strategic significance in Nevada USA (MB Project) from which the Company is planning to produce premium grade fluorspar - acid-spar. 

 

Vipera (VIP)
Vipera (VIP) 

Vipera is a leading provider of mobile financial services platforms. The Vipera platform provides the easiest, fastest, most cost-effective way to develop and operate mobile data services. Solutions powered by Vipera run today on more than 500,000 phones, on hundreds of mobile networks in many countries. Founded in 2005, Vipera has offices in Zurich, Milan and London.

Sponsored by:
AJ Bell Youinvest
Shares

mentor - 04 Apr 2017 23:03 - 45 of 47

Third time lucky? How this miner can double - By Alistair Strang | Tue, 4th April 2017 - 10:19

BMR Group recently blotted its copybook but, strangely, we're not yet ringing alarm bells. But we are perhaps justified in wringing our hands together in frustration as the share price has crashed, once again, through its historical glass ceiling. Or perhaps its flat trend line in pink, but "glass ceiling" sounds more techie.

The issue arose following the 10:1 shuffle with BMR's share price, as immediately afterward a glass ceiling at the 7.15p level appeared.

The first time the price broke above this level in October last year, it was permitted a few days in the sun before being trashed for a while. The second time it bettered this level in February this year, it experienced nearly two months in the glow of misplaced optimism before the price was manipulated once again below 7p.

Presumably the company managed to extract some bad news to spoil the immediate potentials.

On the basis that third time will be the charm, if BMR somehow manages close above 7p we'll be fairly comfortable it intends some proper movement as an initial 10.25p makes a lot of sense with secondary, if bettered, at a longer-term 12.25p and the need to re-calculate its potentials as things start to get a bit silly in the growth potential stakes.

For now, we're basing our optimism on the red uptrend line on the chart below.

The share price completed March with a plunge below this red line, perhaps an early warning this trend could be broken. But, importantly, the downward spike happened right at the open courtesy of a manipulation gap and price down spike.

We like down spikes at the open as they "generally but never always" presage some coming upward travel. When they are prefaced with a gap, the subliminal message is a bit Theresa May.

As the closing price inset highlights, it appears the market was keen not to allow BMR to actually close below the uptrend as this would take it into the region of 4.35p initially with secondary a very probable bounce point at 3.85p.

But hope can be taken, as it seems we're not the only folk with a red crayon.



BMR Group technical analysis graph

Chart.aspx?Provider=Intra&Code=BMR&Size=300*350&Skin=GreenRed&Scale=0&Type=2&Cycle=MINUTE1&Layout=Intra;IntraDate&E=UK&YFormat=&XCycle=Hour2&Fix=1&SV=0Chart.aspx?Provider=EODIntra&Code=BMR&Size=610*350&Skin=RedWhite&Type=3&Scale=0&Cycle=DAY1&Span=MONTH2&OVER=&MA=&IND=;&Layout=2Line;Default;Price;HisDate&XCycle=&XFormat=

black bird - 14 Jan 2018 14:24 - 46 of 47

bramofitch buying ? short stock ? what is the truth, hold long term, await developments, or buy more. s/p 2.42 to buy.BB

HARRYCAT - 03 Aug 2018 13:24 - 47 of 47

03/08/2018 - 7.00am

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

Pursuant to AIM Rule 1 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

BMR Group Plc - ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID
  • Page:
  • 1
  • 2
  • 3
Register now or login to post to this thread.